Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-031619

OPKO HEALTH, INC. · OPK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Md Et Al Frost
Officer — CEO & Chairman · Director · 10% Owner
Period of report
May 18, 2018
Accepted (ET)
May 21, 2018 · 6:24 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000944809

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 18, 2018P5,000$3.83A3,601,951ISee Footnote
Common StockF1May 18, 2018P1,100$3.835A3,603,051ISee Footnote
Common StockF1May 18, 2018P4,500$3.8375A3,607,551ISee Footnote
Common StockF1May 18, 2018P4,400$3.84A3,611,951ISee Footnote
Common StockF1May 18, 2018P400$3.895A3,612,351ISee Footnote
Common StockF1May 18, 2018P4,600$3.90A3,616,951ISee Footnote
Common StockF1May 18, 2018P1,367$3.94A3,618,318ISee Footnote
Common StockF1May 18, 2018P200$3.95A3,618,518ISee Footnote
Common StockF1May 18, 2018P600$3.955A3,619,118ISee Footnote
Common StockF1May 18, 2018P2,833$3.96A3,621,951ISee Footnote
Common StockF1May 18, 2018P3,000$3.99A3,624,951ISee Footnote
Common StockF1May 18, 2018P1,800$3.995A3,626,751ISee Footnote
Common StockF1May 18, 2018P34,200$4.00A3,660,951ISee Footnote
Common StockF1May 18, 2018P3,000$4.02A3,663,951ISee Footnote
Common StockF1May 18, 2018P3,000$4.07A3,666,951ISee Footnote
Common StockF1May 18, 2018P800$4.135A3,667,751ISee Footnote
Common StockF1May 18, 2018P2,853$4.14A3,670,604ISee Footnote
Common StockF1May 18, 2018P1,347$4.15A3,671,951ISee Footnote
Common StockF1May 18, 2018P5,000$4.16A3,676,951ISee Footnote
Common StockF1May 18, 2018P10,000$4.20A3,686,951ISee Footnote
Common StockF1May 18, 2018P5,000$4.31A3,691,951ISee Footnote
Common StockF1May 18, 2018P100$4.335A3,692,051ISee Footnote
Common StockF1May 18, 2018P4,900$4.34A3,696,951ISee Footnote
Common Stockholding———3,068,951D
Common StockF2holding———164,234,443ISee Footnote
Common StockF3holding———20,091,062ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses